🌅 Today's Morning Call
|
S&P Futures
7,247.75
▼ -10.25 (-0.14%)
|
Nasdaq Futures
27,834.75
▼ -1.00 (-0.00%)
|
Dow Futures
49,450.00
▼ -196.00 (-0.39%)
|
|
10Y Treasury
4.38%
▼ -0.01%
|
US Dollar
98.43
▲ +0.42 (+0.43%)
|
Bitcoin
$78,757
▲ +$198 (+0.25%)
|
👀 What to Watch Today
Today's session is light on scheduled economic data, which means headlines and sentiment are going to do the heavy lifting. Keep a close eye on how markets digest the ongoing Trump auto tariff threats that rattled European futures overnight. Any fresh comments from the White House could ripple into domestic auto names and industrials.The Cerebras Systems IPO is the marquee event for growth investors today. The AI chip startup is targeting a price range of $115 to $125 per share for 28 million shares, potentially raising up to $3.5 billion. That would make it one of the larger tech IPOs in recent memory, and the reception it gets will be a real-time sentiment gauge on investor appetite for AI infrastructure plays.
On the corporate front, Tyson Foods (TSN) reports a beat that deserves a closer look. Chicken demand carried the quarter while pricier beef lagged. Expect grocery and food sector stocks to take cues from TSN's guidance commentary as the morning unfolds.
Not every market move can wait. Our text alerts deliver the ones that can't. One short alert, straight to your phone, when something is worth seeing now. No fluff. No noise. No charge.
Text Me the Alerts🌏 Overnight Recap
European markets opened the week under pressure, with the threat of new Trump auto tariffs casting a shadow over the region's export-heavy economies. ETFs tracking European equities, including BBEU, DBEF, and DBEU, are on watch as the situation develops. There was also no shortage of geopolitical noise from the Middle East keeping risk appetite in check.In dealmaking news, Belgian pharma UCB announced a $2.2 billion acquisition of Candid Therapeutics, doubling down on its autoimmune and inflammatory disease pipeline. Biotech M&A is alive and well, and deals like this tend to send ripples through the broader specialty pharma space.
Meanwhile, the Elon Musk versus OpenAI saga took another turn, with a court filing revealing Musk reached out to OpenAI President Greg Brockman about a potential settlement just two days before their Oakland federal trial began. Talks apparently went nowhere, so the legal drama continues. Expect this story to be a slow burn through the trading week.
The Stuff Nobody Brags About (But Should)
📊 Pre-Market Movers
Tyson Foods (TSN) is the standout earnings mover this morning after posting a quarter that topped profit expectations. Chicken sales powered the beat, helping absorb weakness in beef demand as consumers continue to trade down on protein costs. TSN is worth watching for a morning gap and potential follow-through from food and ag-adjacent names.Amazon (AMZN) is in focus after announcing it will open its vast global supply chain network to outside businesses, essentially pitching its logistics operation the way it once pitched AWS cloud services to the world. If this gains traction, it's a meaningful new revenue avenue, and it puts pressure on third-party logistics names who now have a much bigger competitor.
On the IPO front, Cerebras Systems is targeting its market debut today. If the deal prices at the top of the range, it signals real institutional conviction in next-generation AI chip infrastructure, which could lift sentiment across the broader semiconductor space.
🔍 Today's Watchlist
- Cerebras Systems IPO pricing: watch for first-trade reception as a read on AI sector sentiment
- TSN earnings call commentary: listen for demand trends in chicken vs. beef for consumer staples read-through
- AMZN logistics expansion: Amazon opening its supply chain network to outside businesses is a long-term story worth tracking
- 10-Year Treasury at 4.38%: yields are holding relatively steady, giving equities a slight reprieve from rate pressure
- UBS capital rules debate: Swiss lawmakers convening today on new banking regulations with global bank sector implications
I Called the Market Top Last Year. Now I'm Focused on Exposing Hedge Funds
I called the exact top of the market on February 28th before stocks tumbled more than 20%. Before that, I called the exact bottom of the S&P 500 in September 2022.
But my edge isn't just predictions. It's a special class of ETFs that tracks what hedge funds are doing before the rest of the market catches on.
$250,000 turned into $1,000,000 in verified trading profits in a single year.
🎯 The Morning Playbook
With futures pointing modestly lower and no major economic catalysts on the calendar, today's session is shaping up to be a headline-driven, stock-picker's kind of Monday. The Cerebras IPO will set a tone for risk appetite in the AI trade, while tariff headlines out of Washington and Europe could generate volatility in industrials and multinationals.For investors with longer time horizons, Amazon's logistics pivot is the kind of strategic move that looks obvious in hindsight but flies under the radar at announcement. Keep AMZN on your watchlist as that story develops over the coming weeks and months.
Stay nimble, stay informed, and remember that low-volume Monday sessions can exaggerate moves in both directions. The best trades today might be the ones you choose not to make until the picture clears up a bit more.
📰 Further Reading
Years ago, I got into a Tesla-heavy fund before anyone believed in him. That single bet turned into nearly a seven-figure position in less than a decade. Now I'm betting on Elon again - with SpaceX. Bloomberg is calling it "the biggest listing of ALL TIME." A $1.5 TRILLION valuation. A "millionaire-...
Click Here to See How to Secure Your "SpaceX Access Code"For years this ticker has been ignored and overlooked. But Larry Benedict — the hedge fund legend who went 20 years without a losing year — says Trump's "Project 2026" could send it on a rally. He predicts hundreds of billions of dollars are about to flow into this single opportunity. It's not AI. N...
Click here to discover the ticker before Trump triggers "Project 2026"Trump’s GENIUS Act has given crypto its first official federal framework. While attention stays on Bitcoin, one overlooked coin could benefit the most—backed by skyrocketing volume, early fund activity, and pro-crypto policy momentum.
See the #1 Coin Riding Trump’s Crypto Revolution



